Kalvista Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Kalvista Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kalvista Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Kalvista Pharmaceuticals by Goldman Sachs Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $2.5M | 213k | 11.78 |
2024-03-31 | $710k | 60k | 11.86 |
2023-12-31 | $4.1M | 331k | 12.25 |
2023-09-30 | $2.0M | 209k | 9.63 |
2023-06-30 | $2.6M | 293k | 9.00 |
2023-03-31 | $2.2M | 276k | 7.86 |
2022-12-31 | $2.3M | 346k | 6.76 |
2022-06-30 | $3.0M | 301k | 9.85 |
2022-03-31 | $2.5M | 167k | 14.74 |
2021-12-31 | $1.3M | 99k | 13.23 |
2021-09-30 | $1.2M | 69k | 17.46 |
2021-03-31 | $1.4M | 55k | 25.69 |
2020-12-31 | $201k | 11k | 19.02 |
2020-06-30 | $445k | 37k | 12.10 |
2019-12-31 | $360k | 20k | 17.81 |
2019-09-30 | $546k | 47k | 11.59 |
2019-06-30 | $463k | 21k | 22.14 |
2019-03-31 | $1.1M | 38k | 28.63 |
2017-12-31 | $151k | 16k | 9.72 |